Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.40% | 54.46% | 53.74% | 78.64% | 38.57% |
| Total Depreciation and Amortization | 14.29% | 9.09% | 15.00% | 4.76% | 16.67% |
| Total Amortization of Deferred Charges | -31.25% | -45.45% | 0.00% | 3.13% | -3.03% |
| Total Other Non-Cash Items | -60.95% | -97.48% | -97.55% | -113.42% | -69.49% |
| Change in Net Operating Assets | 483.33% | 1,044.44% | 210.38% | 53.15% | 84.35% |
| Cash from Operations | 0.00% | 51.14% | 79.96% | 0.88% | 22.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.10% | -239.02% | 73.26% | 40.00% | 53.61% |
| Issuance of Common Stock | -- | -- | -- | 630.30% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 354.55% | 207.32% | -300.00% | 566.67% | -105.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.08% | 64.51% | 69.33% | 63.54% | -127.85% |
